Viltepso

viltolarsen · NS Pharma, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Viltepso, covering 2020-08-12 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) [Phase 3]